4//SEC Filing
FERRARI LOUIS 4
Accession 0001181431-12-007983
CIK 0000722104other
Filed
Feb 12, 7:00 PM ET
Accepted
Feb 13, 6:33 AM ET
Size
10.1 KB
Accession
0001181431-12-007983
Insider Transaction Report
Form 4
FERRARI LOUIS
SVP, North American Commerical
Transactions
- Award
Common Stock, $.01 par value per share
2012-02-01$2.26/sh+310,000$700,600→ 354,603 total - Award
Common Stock, $.01 par value per share
2011-11-30$2.13/sh+381$812→ 44,603 total - Award
Common Stock, $.01 par value per share
2011-08-31$3.66/sh+222$813→ 44,222 total - Award
Option to Purchase Common Stock, $.01 par value
2012-02-01$2.26/sh+100,000$226,000→ 100,000 totalExercise: $2.26From: 2013-02-01Exp: 2022-02-01→ Common Stock, $.01 par value per share (100,000 underlying)
Footnotes (3)
- [F1]The right to receive these shares is pursuant to a restricted stock grant that vests as to 50% on each of the first and second anniversaries of the grant date, provided that the grantee remains employed by the Company on these dates.
- [F2]Consists of shares acquired pursuant to the Savient Pharmaceuticals, Inc. 1998 Employee Stock Purchase Plan, which were not previously reported.
- [F3]These options vest as to 25% on each of the first four anniversaries of the grant date, provided that the grantee remains employed by the Company on these dates.
Documents
Issuer
SAVIENT PHARMACEUTICALS INC
CIK 0000722104
Entity typeother
Related Parties
1- filerCIK 0001513697
Filing Metadata
- Form type
- 4
- Filed
- Feb 12, 7:00 PM ET
- Accepted
- Feb 13, 6:33 AM ET
- Size
- 10.1 KB